rs273898674
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Novel BRCA1 deleterious mutation (c.1918C>T) in familial breast and ovarian cancer syndrome who share a common ancestry.
|
24633894 |
2014 |
rs397508917
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Here, we report the characterization of the BRCA1 c.190T>C (p.Cys64Arg) mutation, mapped to the RING-finger domain coding region, that we detected in 43 hereditary breast/ovarian cancer (HBOC) families, for the large part originating from the province of Bergamo (Northern Italy).
|
24516540 |
2014 |
rs397509039
|
|
|
0.010 |
GeneticVariation |
BEFREE |
This report describes functional analysis of two BRCA1 missense mutations (Asp67Glu and Thr1051Ser) observed in the familial breast/ovarian cancer patients in Thailand.
|
19865540 |
2009 |
rs80357033
|
|
|
0.010 |
GeneticVariation |
BEFREE |
This report describes functional analysis of two BRCA1 missense mutations (Asp67Glu and Thr1051Ser) observed in the familial breast/ovarian cancer patients in Thailand.
|
19865540 |
2009 |
rs886037971
|
|
|
0.010 |
GeneticVariation |
BEFREE |
We demonstrate that disruption of alternative transcript ratios is the mechanism causing hereditary breast/ovarian cancer associated with the BRCA1 R71G mutation.
|
19123044 |
2009 |
rs41293459
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
Combining Homologous Recombination and Phosphopeptide-binding Data to Predict the Impact of BRCA1 BRCT Variants on Cancer Risk.
|
30257991 |
2019 |
rs45553935
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
Age-adjusted association of homologous recombination genes with ovarian cancer using clinical exomes as controls.
|
31341520 |
2019 |
rs45553935
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
Biallelic germline BRCA1 mutations in a patient with early onset breast cancer, mild Fanconi anemia-like phenotype, and no chromosome fragility.
|
31347298 |
2019 |
rs45553935
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
Impact of amino acid substitutions at secondary structures in the BRCT domains of the tumor suppressor BRCA1: Implications for clinical annotation.
|
30765603 |
2019 |
rs80357132
|
|
G |
0.700 |
GeneticVariation |
CLINVAR |
Impact of amino acid substitutions at secondary structures in the BRCT domains of the tumor suppressor BRCA1: Implications for clinical annotation.
|
30765603 |
2019 |
rs80358108
|
|
C |
0.700 |
GeneticVariation |
CLINVAR |
Quantifying BRCA1 and BRCA2 mRNA Isoform Expression Levels in Single Cells.
|
30736279 |
2019 |
rs142074233
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
BRCA germline mutations in an unselected nationwide cohort of Chinese patients with ovarian cancer and healthy controls.
|
30078507 |
2018 |
rs273901754
|
|
A |
0.700 |
GeneticVariation |
CLINVAR |
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations.
|
29446198 |
2018 |
rs397507241
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
Accurate classification of BRCA1 variants with saturation genome editing.
|
30209399 |
2018 |
rs397507241
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
Screening of over 1000 Indian patients with breast and/or ovarian cancer with a multi-gene panel: prevalence of BRCA1/2 and non-BRCA mutations.
|
29470806 |
2018 |
rs397508902
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations.
|
29446198 |
2018 |
rs397509164
|
|
GTTCT |
0.700 |
CausalMutation |
CLINVAR |
Difference in Risk of Breast and Ovarian Cancer According to Putative Functional Domain Regions in Korean BRCA1/2 Mutation Carriers.
|
29673794 |
2018 |
rs398122685
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations.
|
29446198 |
2018 |
rs41293459
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
Trans-activation-based risk assessment of BRCA1 BRCT variants with unknown clinical significance.
|
30458859 |
2018 |
rs41293459
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
The BRCA1 c. 5096G>A p.Arg1699Gln (R1699Q) intermediate risk variant: breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium.
|
28490613 |
2018 |
rs45553935
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
Mechanism for survival of homozygous nonsense mutations in the tumor suppressor gene BRCA1.
|
29712865 |
2018 |
rs45553935
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
Subsequent breast and high grade serous carcinomas after risk-reducing salpingo-oophorectomy in BRCA mutation carriers and patients with history of breast cancer.
|
30055521 |
2018 |
rs762635795
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
Screening of over 1000 Indian patients with breast and/or ovarian cancer with a multi-gene panel: prevalence of BRCA1/2 and non-BRCA mutations.
|
29470806 |
2018 |
rs80356857
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
The germline mutational landscape of BRCA1 and BRCA2 in Brazil.
|
29907814 |
2018 |
rs80356862
|
|
C |
0.700 |
GeneticVariation |
CLINVAR |
Description of Genetic Variants in BRCA Genes in Mexican Patients with Ovarian Cancer: A First Step towards Implementing Personalized Medicine.
|
29997359 |
2018 |